Selection of ventricular‐like cardiomyocytes from ES cells in vitro
Authors:
Open Access
- 1 December 2000
- journal article
- research article
- Published by Wiley in The FASEB Journal
- Vol. 14 (15) , 2540-2548
Abstract
Ischemic disorders of the heart can cause an irreversible loss of cardiomyocytes resulting in a substantial decrease of cardiac output. The therapy of choice is heart transplantation, a technique that is hampered by the low number of donor organs. In the present study, we describe the specific labeling, rapid but gentle purification and characterization of cardiomyocytes derived from mouse pluripotent embryonic stem (ES) cells. To isolate the subpopulation of ventricular‐like cardiomyocytes, ES cells were stable transfected with the enhanced green fluorescent protein (EGFP) under transcriptional control of the ventricular‐specific 2.1 kb myosin light chain‐2v (MLC‐2v) promoter and the 0.5 kb enhancer element of the cytomegalovirus (CMV enh ). First fluorescent cells were detected at day 6 + 8 of differentiation within EBs. Four weeks after initiation of differentiation 25% of the cardiomyocyte population displayed fluorescence. Immunohistochemistry revealed the exclusive cardiomyogenic nature of EGFP‐positive cells. This was further corroborated by electrophysiological studies where preferentially ventricular phenotypes, but no pacemaker‐like cardiomyocytes, were detected among the EGFP‐positive population. The enzymatic digestion of EBs, followed by Percoll gradient centrifugation and fluorescence‐activated cell sorting, resulted in a 97% pure population of cardiomyocytes. Based on this study, ventricular‐like cardiomyocytes can be generated in vitro from EBs and labeled using CMV enh /MLC‐2v‐driven marker genes facilitating an efficient purification. This method may become an important tool for future cell replacement therapy of ischemic cardiomyopathy especially after the proof of somatic differentiation of human ES cells in vitro. —Müller, M., Fleischmann, B. K., Selbert, S., Ji, G. J., Endl, E., Middeler, G., Mueller, O. J., Schlenke, P., Frese, S., Wobus, A. M., Hescheler, J., Katus, H. A., Franz, W. M. Selection of ventricular‐like cardiomyocytes from ES cells in vitro . FASEB J. 14, 2540–2548 (2000)Keywords
Funding Information
- Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung
This publication has 36 references indexed in Scilit:
- Regenerating functional myocardium: Improved performance after skeletal myoblast transplantationNature Medicine, 1998
- From totipotent embryonic stem cells to spontaneously contracting smooth muscle cells: a retinoic acid and db‐cAMP in vitro differentiation modelThe FASEB Journal, 1997
- Retinoic Acid Accelerates Embryonic Stem Cell-Derived Cardiac Differentiation and Enhances Development of Ventricular CardiomyocytesJournal of Molecular and Cellular Cardiology, 1997
- Genetically selected cardiomyocytes from differentiating embronic stem cells form stable intracardiac grafts.Journal of Clinical Investigation, 1996
- Differentiation of pluripotent embryonic stem cells into the neuronal lineage in vitro gives rise to mature inhibitory and excitatory neuronsMechanisms of Development, 1995
- Muscle Cell Differentiation of Embryonic Stem Cells Reflects Myogenesis in Vivo: Developmentally Regulated Expression of Myogenic Determination Genes and Functional Expression of Ionic CurrentsDevelopmental Biology, 1994
- Formation of Nascent Intercalated Disks Between Grafted Fetal Cardiomyocytes and Host MyocardiumScience, 1994
- Morphological characterization of cardiomyocytes isolated from a transplantable cardiac tumor derived from transgenic mouse atria (AT-1 cells).Circulation Research, 1991
- Pluripotent mouse embryonic stem cells are able to differentiate into cardiomyocytes expressing chronotropic responses to adrenergic and cholinergic agents and Ca2+ channel blockersDifferentiation, 1991
- Myocyte mitotic division in the aging mammalian rat heart.Circulation Research, 1991